Facing the COVID-19 epidemic in NYC: a stochastic agent-based model of various intervention strategies

This article has been Reviewed by the following groups

Read the full article See related articles

Abstract

Global spread of coronavirus disease 2019 (COVID-19) has created an unprecedented infectious disease crisis worldwide. Despite uncertainties about COVID-19, model-based forecasting of competing mitigation measures on its course is urgently needed to inform mitigation policy. We used a stochastic agent-based microsimulation model of the COVID-19 epidemic in New York City and evaluated the potential impact of quarantine duration (from 4 to 16 weeks), quarantine lifting type (1-step lifting for all individuals versus a 2-step lifting according to age), post-quarantine screening, and use of a hypothetical effective treatment against COVID-19 on the disease’s cumulative incidence and mortality, and on ICU-bed occupancy. The source code of the model has been deposited in a public source code repository (GitHub®). The model calibrated well and variation of model parameter values had little impact on outcome estimates. While quarantine is efficient to contain the viral spread, it is unlikely to prevent a rebound of the epidemic once lifted. We projected that lifting quarantine in a single step for the full population would be unlikely to substantially lower the cumulative mortality, regardless of quarantine duration. By contrast, a two-step quarantine lifting according to age was associated with a substantially lower cumulative mortality and incidence, up to 71% and 23%, respectively, as well as lower ICU-bed occupancy. Although post-quarantine screening was associated with diminished epidemic rebound, this strategy may not prevent ICUs from being overcrowded. It may even become deleterious after a 2-step quarantine lifting according to age if the herd immunity effect does not had sufficient time to become established in the younger population when the quarantine is lifted for the older population. An effective treatment against COVID-19 would considerably reduce the consequences of the epidemic, even more so if ICU capacity is not exceeded.

Article activity feed

  1. SciScore for 10.1101/2020.04.23.20076885: (What is this?)

    Please note, not all rigor criteria are appropriate for all manuscripts.

    Table 1: Rigor

    NIH rigor criteria are not applicable to paper type.

    Table 2: Resources

    No key resources detected.


    Results from OddPub: Thank you for sharing your code.


    Results from LimitationRecognizer: We detected the following sentences addressing limitations in the study:
    Our study has several limitations. First, the model was calibrated on the diagnosis and mortality rates available from the CDC (6). However, we cannot exclude the possibility that these parameters are underestimates. Nevertheless, the observed differences across scenarios remained unchanged overall when considering a much higher and unlikely (26, 41, 42) diagnosis rate of 1 in 10, except for the efficacy of the post-quarantine screening on the course of the epidemic, which was much greater under this assumption, contributing to the robustness of our conclusions. Second, the contact matrix was approximated using multiple assumptions for each type of contact. However, we found that the model calibrated well, suggesting that although the assumptions made for unknown parameters, such as the frequency of meeting friends or the number of people met during shopping, can be criticized, the overall model, for which most parameter values were based on prior findings (eTable 1), may adequately predict the course of the COVID-19 epidemic in NYC. Third, we considered that infected people could develop immunity for at least several months following standard assumptions (53). However, post-COVID-19 immunity length remains unknown (54). Fourth, although the main differences observed were substantial and remained similar to a ±20% variation of each model parameter value, suggesting the generalizability of our results to other locales, future studies using this model and adjusting it to other ...

    Results from TrialIdentifier: No clinical trial numbers were referenced.


    Results from Barzooka: We did not find any issues relating to the usage of bar graphs.


    Results from JetFighter: We did not find any issues relating to colormaps.


    Results from rtransparent:
    • Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
    • Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
    • No protocol registration statement was detected.

    About SciScore

    SciScore is an automated tool that is designed to assist expert reviewers by finding and presenting formulaic information scattered throughout a paper in a standard, easy to digest format. SciScore checks for the presence and correctness of RRIDs (research resource identifiers), and for rigor criteria such as sex and investigator blinding. For details on the theoretical underpinning of rigor criteria and the tools shown here, including references cited, please follow this link.